Xvivo Perfusion AB (publ) (XVIPF)
USD 41.1
(0.0%)
USD 41.1
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 250.56 Million SEK | -17.29% |
| 2022 | 302.94 Million SEK | 17.81% |
| 2021 | 257.14 Million SEK | 81.28% |
| 2020 | 141.84 Million SEK | 149.0% |
| 2019 | 56.96 Million SEK | 23.48% |
| 2018 | 46.13 Million SEK | 34.87% |
| 2017 | 34.2 Million SEK | 4.03% |
| 2016 | 32.88 Million SEK | 70.33% |
| 2015 | 19.3 Million SEK | -24.34% |
| 2014 | 25.51 Million SEK | -17.5% |
| 2013 | 30.93 Million SEK | 20.1% |
| 2012 | 25.75 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 250.54 Million SEK | -0.01% |
| 2024 Q2 | 248.18 Million SEK | -0.94% |
| 2024 Q3 | 195.01 Million SEK | -21.42% |
| 2023 FY | 250.56 Million SEK | -17.29% |
| 2023 Q4 | 250.56 Million SEK | -18.91% |
| 2023 Q1 | 292.98 Million SEK | -3.29% |
| 2023 Q2 | 285.09 Million SEK | -2.69% |
| 2023 Q3 | 308.99 Million SEK | 8.38% |
| 2022 Q4 | 302.94 Million SEK | 16.58% |
| 2022 Q3 | 259.86 Million SEK | 8.73% |
| 2022 Q2 | 239 Million SEK | 6.23% |
| 2022 Q1 | 224.98 Million SEK | -12.51% |
| 2022 FY | 302.94 Million SEK | 17.81% |
| 2021 Q4 | 257.14 Million SEK | 95.05% |
| 2021 Q1 | 146.21 Million SEK | 3.08% |
| 2021 Q2 | 138.82 Million SEK | -5.06% |
| 2021 Q3 | 131.83 Million SEK | -5.03% |
| 2021 FY | 257.14 Million SEK | 81.28% |
| 2020 Q1 | 55.4 Million SEK | -2.74% |
| 2020 Q2 | 50.75 Million SEK | -8.39% |
| 2020 Q3 | 77.2 Million SEK | 52.11% |
| 2020 Q4 | 141.84 Million SEK | 83.73% |
| 2020 FY | 141.84 Million SEK | 149.0% |
| 2019 Q1 | 58.61 Million SEK | 27.05% |
| 2019 FY | 56.96 Million SEK | 23.48% |
| 2019 Q3 | 74.59 Million SEK | 5.2% |
| 2019 Q2 | 70.9 Million SEK | 20.98% |
| 2019 Q4 | 56.96 Million SEK | -23.64% |
| 2018 FY | 46.13 Million SEK | 34.87% |
| 2018 Q2 | 41.31 Million SEK | 22.74% |
| 2018 Q3 | 44.11 Million SEK | 6.78% |
| 2018 Q4 | 46.13 Million SEK | 4.58% |
| 2018 Q1 | 33.66 Million SEK | -1.6% |
| 2017 Q2 | 28.76 Million SEK | 13.96% |
| 2017 Q1 | 25.24 Million SEK | -23.24% |
| 2017 Q3 | 30.18 Million SEK | 4.92% |
| 2017 Q4 | 34.2 Million SEK | 13.33% |
| 2017 FY | 34.2 Million SEK | 4.03% |
| 2016 Q2 | 23.96 Million SEK | 14.38% |
| 2016 Q1 | 20.94 Million SEK | 8.5% |
| 2016 FY | 32.88 Million SEK | 70.33% |
| 2016 Q4 | 32.88 Million SEK | 7.5% |
| 2016 Q3 | 30.58 Million SEK | 27.67% |
| 2015 Q1 | 22.52 Million SEK | -11.71% |
| 2015 FY | 19.3 Million SEK | -24.34% |
| 2015 Q4 | 19.3 Million SEK | -12.2% |
| 2015 Q3 | 21.98 Million SEK | -13.03% |
| 2015 Q2 | 25.28 Million SEK | 12.22% |
| 2014 Q2 | 39.44 Million SEK | 19.23% |
| 2014 Q1 | 33.08 Million SEK | 6.95% |
| 2014 FY | 25.51 Million SEK | -17.5% |
| 2014 Q4 | 25.51 Million SEK | 16.03% |
| 2014 Q3 | 21.99 Million SEK | -44.24% |
| 2013 Q2 | 19.56 Million SEK | 10.52% |
| 2013 Q4 | 30.93 Million SEK | 31.51% |
| 2013 Q1 | 17.7 Million SEK | -31.25% |
| 2013 FY | 30.93 Million SEK | 20.1% |
| 2013 Q3 | 23.52 Million SEK | 20.2% |
| 2012 FY | 25.75 Million SEK | 0.0% |
| 2012 Q4 | 25.75 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | -1161.318% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -11730.312% |
| Össur hf. | 688.8 Million USD | 63.623% |
| QHSLab, Inc. | 2.05 Million USD | -12080.847% |
| Wellstar International, Inc. | 55.99 Million USD | -347.515% |
| Össur hf. | 688.8 Million USD | 63.623% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -8398.536% |
| Aurora Spine Corporation | 6.65 Million USD | -3665.907% |
| BrainsWay Ltd. | 15.31 Million USD | -1536.189% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | -1407.363% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -446.576% |
| Vivos Inc. | 245 Thousand USD | -102170.167% |
| Kelyniam Global, Inc. | 1.01 Million USD | -24636.632% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -90811.928% |
| Zecotek Photonics Inc. | 5.86 Million USD | -4169.6% |
| Avitar, Inc. | 11.59 Million USD | -2061.256% |
| Nanomix Corporation | 14.81 Million USD | -1591.328% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -1458.194% |
| Theraclion SA | 13.01 Million EUR | -1824.977% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | -12267.534% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -6819.476% |
| Lombard Medical, Inc. | 53.79 Million USD | -365.788% |
| ALR Technologies Inc. | 24.5 Million USD | -922.495% |
| Stratec SE | 271.97 Million USD | 7.87% |
| Vycor Medical, Inc. | 4.31 Million USD | -5703.129% |
| Heart Tronics, Inc. | 1.09 Million USD | -22787.15% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 89.922% |
| VMS Rehab Systems, Inc. | 201.36 USD | -124436729.559% |
| NewCardio, Inc. | 6.01 Million USD | -4067.316% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -4476.548% |
| Ingen Technologies, Inc. | 5.7 Million USD | -4288.544% |
| Odyssey Group International, Inc. | 6.61 Million USD | -3689.724% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -10127.985% |
| Wellness Center USA, Inc. | 5.12 Million USD | -4789.859% |
| SANUWAVE Health, Inc. | 65.59 Million USD | -281.995% |
| IR-Med Inc. | 634 Thousand USD | -39421.451% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -4475.239% |
| Polarean Imaging plc | 2.58 Million USD | -9609.832% |
| United American Healthcare Corporation | 119 Thousand USD | -210459.664% |
| ECGI Holdings, Inc. | 11.94 Million USD | -1998.479% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -10522.668% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -18825.153% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -17224.178% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -36877.58% |
| Urologix, Inc. | 12.64 Million USD | -1881.699% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -4543.497% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -2853.933% |
| SS Innovations International, Inc. | 11.18 Million USD | -2140.978% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -47591.702% |
| Smith & Nephew plc | 4.76 Billion USD | 94.74% |
| NIOX Group Plc | 9.8 Million USD | -2456.248% |
| Fuse Medical, Inc. | 15.11 Million USD | -1558.272% |
| Broncus Holding Corporation | 10.43 Million USD | -2301.859% |
| Brain Scientific Inc. | 7.42 Million USD | -3273.989% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -641.243% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -31454.212% |